共 100 条
- [1] Swanson RL(2005)Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson’s disease Eur J Nucl Med Mol Imaging 32 302-307
- [2] Newberg AB(2013)The role of neuroimaging in the diagnosis of Parkinson’s disease Int J Integr Med 1 1-5
- [3] Acton PD(2006)Parkinson’s disease and dopamine transporter neuroimaging: a critical review Sao Paulo Med J 124 168-175
- [4] Siderowf A(2012)SPECT molecular imaging in Parkinson’s disease J Biomed Biotechnol 2012 412486-1338
- [5] Wintering N(2013)Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update J Nucl Med 54 1331-1423
- [6] Alavi A(2003)Role of dopamine transporter imaging in routine clinical practice Mov Disord 18 1415-689
- [7] Zhang L(2001)Echogenicity of the substantia nigra in Parkinson’s disease and its relation to clinical findings J Neurol 248 684-2054
- [8] Liu J(2006)Parkinson’s disease: diagnosis and treatment Am Fam Physician 74 2046-1005
- [9] Shih MC(2003)Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson’s disease patients J Nucl Med 44 999-673
- [10] Hoexter MQ(2012)Dopamine transporter imaging in clinically unclear cases of parkinsonism and the importance of scans without evidence of dopaminergic deficit (SWEDDs) Arq Neuropsiquiatr 70 667-213